Blog Archive

Saturday, June 11, 2022

NYMX

 





  • Nymox Pharmaceutical Corporation(NASDAQ: NYMX) tumbled 63.9% to close at $0.4555 on Monday after the company received a #Refusal to File letter from the FDA regarding the company's New Drug Application for fexapotide triflutate.

No comments:

Post a Comment

SGNX

 

Labels